Tuesday, April 29, 2025

Latest

MustGrow Biologics Isolates Third Molecule From Mustard Plant

MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different molecules. The firm this morning announced that it has now isolated and concentrated thiocyanate, the third such molecule to be extracted from the plant.

Thiocyanate is reponsible for the systemic activity behind the mustard plants natural herbicidal properties. In layman terms, the molecule works to kill weeds, with the company having previously demonstrated proof of concept success without isolating the molecule. Those prior studies will now be built upon following the isolation of this molecule.

The extract reportedly has the potential of being a natural organic non-selective bioherbicide that is soil active and contains systemic translocated properties. As per the company, this is significant as “given that the leading synthetic herbicide glyphosate is not soil active, and only acts on the above ground parts of the weed it contacts.” The result is that it could either replace or compliment the use of glyphosate while being a natural and organic solution.

The company is now in the process of greenhouse testing the extract both on a stand-alone basis as well as in combination with the firms TerraMG product. The former is a non-selective bioherbicide, while the latter is a biopesticide used to control disease and pests.

MustGrow Biologics last traded at $1.95 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

MustGrow Biologics Reports Positive Trial Results In Colombia

MustGrow Biologics (CSE: MGRO) this morning released further results from ongoing field trials being conducted...

Monday, July 12, 2021, 07:33:27 AM

MustGrow Biologics Sees Positive Soil Health Results In Study

MustGrow Biologics (CSE: MGRO) has seen positive results from a third party confirmatory study related...

Tuesday, January 19, 2021, 07:29:06 AM

MustGrow Biologics Receives $1.5 Million From Exercise Of Warrants

MustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has...

Thursday, January 14, 2021, 07:57:13 AM

MustGrow Biologics Demonstrates 100% Control Of Panama Disease In Lab Tests

MustGrow Biologics (CSE: MGRO) has received the results from initial laboratory testing that was conducted...

Tuesday, December 1, 2020, 08:31:08 AM

Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics

Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO...

Monday, December 21, 2020, 01:00:00 PM